New drug wins FDA approval to treat chronic migraines

preview_player
Показать описание
U.S. regulators have approved the first drug designed to prevent chronic migraines, clearing the monthly shot Aimovig to hit the market soon. It's the first in a new class of long-acting drugs for preventing migraines. CBS News' Dr. Max Gomez reports.
Рекомендации по теме
join shbcf.ru